USP4 Antibodies

Santa Cruz Biotechnology features a diverse variety of USP4 monoclonal antibodies for advanced research in cellular signaling and protein regulation. USP4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ubiquitin-specific protease 4 (USP4) plays a critical role in the regulation of protein degradation and cellular homeostasis by removing ubiquitin moieties from target proteins. USP4 maintains proper cellular functions and responses to stress, making it a significant player in various biological processes, including cell cycle regulation and apoptosis. Dysregulation of USP4 has been implicated in several diseases, including cancer, highlighting its importance for therapeutic advancements. Understanding USP4's molecular mechanisms and interactions can lead to new insights in disease treatment and prevention. Investigating USP4's role in cellular pathways may reveal novel therapeutic targets. Research using USP4 monoclonal antibodies continues to advance scientific understanding of cellular processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their pursuit of scientific discoveries and medical breakthroughs.